These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36346683)

  • 21. Management of patients in a combined thyroid eye clinic in secondary care.
    Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B
    Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.
    Wang Y; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Douglas RS
    Endocr Pract; 2022 Sep; 28(9):842-846. PubMed ID: 35714862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tocilizumab for thyroid eye disease.
    Hamed Azzam S; Kang S; Salvi M; Ezra DG
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012984. PubMed ID: 30480323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
    Vashdi I; Gur Z
    Harefuah; 2022 Apr; 161(4):223-227. PubMed ID: 35466606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
    Iacobæus L; Sahlin S
    Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in clinical presentation and prognosis of thyroid eye disease.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Eur J Ophthalmol; 2021 Sep; 31(5):2717-2723. PubMed ID: 33158379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
    Yu CY; Ford RL; Wester ST; Shriver EM
    Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in patients with thyroid eye disease.
    Bahmani-Kashkouli M; Pakdel F; Astaraki A; Hashemi M; Honarbakhsh Y; Mirarmandehi B; Jam S
    J Ophthalmic Vis Res; 2009 Jul; 4(3):164-8. PubMed ID: 23198067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid disease-specific quality of life questionnaires - A systematic review.
    Uslar V; Becker C; Weyhe D; Tabriz N
    Endocrinol Diabetes Metab; 2022 Sep; 5(5):e357. PubMed ID: 35856310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Survey on the Management of Thyroid Eye Disease Among American and European Thyroid Association Members.
    Brito JP; Nagy EV; Singh Ospina N; Zˇarković M; Dosiou C; Fichter N; Lucarelli MJ; Hegedüs L
    Thyroid; 2022 Dec; 32(12):1535-1546. PubMed ID: 35946071
    [No Abstract]   [Full Text] [Related]  

  • 32. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?
    Wall JR; Lahooti H
    Endokrynol Pol; 2010; 61(2):222-7. PubMed ID: 20464711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
    Wall JR; Lahooti H
    Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of pediatric thyroid eye disease: the Asian experience.
    Sim B; Chng CL; Audrey C; Seah LL
    Orbit; 2022 Feb; 41(1):69-78. PubMed ID: 33059514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis.
    Estcourt S; Vaidya B; Quinn A; Shepherd M
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):635-9. PubMed ID: 17973942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.
    Chin YH; Ng CH; Lee MH; Koh JWH; Kiew J; Yang SP; Sundar G; Khoo CM
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):363-374. PubMed ID: 32691849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
    Estcourt S; Hickey J; Perros P; Dayan C; Vaidya B
    Eur J Endocrinol; 2009 Sep; 161(3):483-7. PubMed ID: 19542244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease.
    Pampín-Sánchez R; Martínez-Mugica-Barbosa C; Fonseca-Aizpuru EM; Barbazán-Vázquez FJ; Fernández-González B; Buznego-Súárez L
    Med Clin (Barc); 2023 Feb; 160(3):113-117. PubMed ID: 36088128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
    Poon SHL; Cheung JJ; Shih KC; Chan YK
    Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.